Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Listen: When the grind gets gloomy, experts discuss mental health challenges and entrepreneurship
About 72 percent of entrepreneurs have self-reported mental health concerns, according to a study done by the University of California San Francisco. More specifically, about 30 percent of entrepreneurs experience depression and about 30 percent experience ADHD, the same study found. In recognition of Mental Health Awareness Month, Startland News and Think Big’s May Innovation…
6 tips and tricks to stay sane while scaling fast
Frequently taking on more demands and shirking personal care, entrepreneurs’ work-life balance often skews toward work. Deadlines, finding clients, making payroll and dozens of other stressors can put entrepreneurs at risk of mental illness or compound existing challenges. Furthermore, entrepreneurs are disproportionately affected by such issues as ADHD, bipolar disorder and depression, according to studies…
Video: How to use the lean model canvas for fun and profit
Editor’s note: Continuing our mission to help area entrepreneurs and startups grow, we’re happy to share with you a video from our friends at Kansas City-based tech agency Crema. Learn more about the agency here. Starting a business, or launching a product is really hard. Most people will tell you to first come up with…
Visualize Kansas City’s digital divide with this new Smart City tool
A canyon between those with consistent access to computers and the Internet and those who don’t, the digital divide is often discussed in the abstract. However difficult to conceptualize in a broad scale, the digital divide in Kansas City has real economic, cultural and social implications in our community. That’s why the City of Kansas…